Dr. Joseph Ecker, whose research focuses on genomic and epigenomic regulation in mammals and plants, joins Zymo Research’s Scientific Advisory Board. IRVINE, Calif.,, July 24, 2018 /PRNewswire/ — Zymo Research Corp. has announced the appointment of Joseph R. Ecker, Ph.D., to Zymo Research’s Scientific Advisory Board. Dr. Ecker serves as Professor of Plant Molecular and... Read more
23 Jul It is with great sadness that the Board of Oxford Instruments plc announces the death of its Chairman, Alan Thomson. Alan has been Chairman since September 2016 and brought a wealth of experience and wisdom to the role. Ian Barkshire (Chief Executive) commented: “Alan’s commitment and passion in driving improvement have been inspirational... Read more
Agilent Receives Sustainability Leadership Award Business Intelligence Group Recognizes Company’s Innovative Product Designs SANTA CLARA, Calif., July 23, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it has earned the 2018 Sustainability Leadership Award from the Business Intelligence Group for its commitment to sustainability through innovative product design. The Leadership Award, judged by a... Read more
Basel, 23 July 2018 Roche receives CE Mark for its Accu-Chek Solo micropump system The Accu-Chek Solo micropump is a small, tube-free insulin delivery system that offers users the choice to bolus directly from the pump or from the fully-functional handheld as well as to detach and re-attach the pump without wasting insulin. The Accu-Chek... Read more
Basel, 23 July 2018 Roche receives CE Mark for its Accu-Chek Solo micropump system The Accu-Chek Solo micropump is a small, tube-free insulin delivery system that offers users the choice to bolus directly from the pump or from the fully-functional handheld as well as to detach and re-attach the pump without wasting insulin. The Accu-Chek... Read more
Basel, 20 July 2018 Roche to present new data demonstrating the breadth and depth of its Alzheimer’s programme at the upcoming Alzheimer’s Association International Conference Late-breaking Phase II exploratory analysis of investigational crenezumab to show impact on amyloid beta oligomer levels in CSF Two year open-label extension updates for investigational gantenerumab will include data on... Read more
Basel, 20 July 2018 Roche to present new data demonstrating the breadth and depth of its Alzheimer’s programme at the upcoming Alzheimer’s Association International Conference Late-breaking Phase II exploratory analysis of investigational crenezumab to show impact on amyloid beta oligomer levels in CSF Two year open-label extension updates for investigational gantenerumab will include data on... Read more
17 JUL 2018 | DARMSTADT, GERMANY First prize to be awarded 2019 for work on a visionary product to protect humanity from newly emerging viral diseases Merck KGaA, Darmstadt, Germany, committed to “Future Insight Prize” for the next 35 years Announcement made at “Curious2018 – Future Insight” conference premiere Darmstadt, Germany, July 17, 2018 – Merck KGaA,... Read more
TUCSON, Ariz., July 17, 2018 /PRNewswire/ — PathogenDx Corporation, the innovative provider of DNA-based pathogen testing technology for the cannabis, botanical, food and agriculture industries, announced today the successful completion of a $3.4 million capital raise, completing the company’s convertible note round. The PathogenDx capital raise was co-led by Altitude Investment Management and The Panther Opportunity Fund. Other key funders include CanopyVentures,... Read more
17 July 2018, Cambridge, MA — BioData has announced the appointment of Steve Yemm as CEO, following a decade of growth in the adoption of its flagship product Labguru. This secure, compliant, web and cloud-based Electronic Lab Notebook (ELN) is trusted by over 30,000 users worldwide who rely on it to plan and document experiments,... Read more